Cancer Immunotherapy Drugs Driving End-of-Life Cost Increases

March 2, 2023

156

Immunotherapy drugs accounted for 84% of the overall increase in Medicare Part B spending for end-of-life outpatient cancer care.
Medscape Medical News

Read it later

LEAVE A REPLY Cancel reply

Time Management Tips

Recommended Tweets

Stand Up To Cancer ·
@SU2C

Klaus shares how a stage 3 melanoma diagnosis changed his life, and how cancer research and a clinical trial helped save it. 💛 #StandUpToCancer https://t.co/XD10pM4DWl

View on Twitter

Stand Up To Cancer ·
@SU2C

Today we celebrate SU2C’s 13th anniversary. In 2008, we began our mission to #StandUpToCancer. Because of donors and supporters like you, each day we are getting closer to a world with more long-term cancer survivors. Thank you for Standing Up with us for the last 13 years. 💛 https://t.co/BPSFt09TEr

View on Twitter

Stand Up To Cancer ·
@SU2C

Cancer research has the power to bring us one step closer to a world with more long-term survivors. This #CancerResearchMonth, you can be part of the next lifesaving breakthrough. Give now at https://t.co/tNxh7nWw6c. #StandUpToCancer https://t.co/2YI0bmJU9b

View on Twitter

Stand Up To Cancer ·
@SU2C

After being diagnosed with stage 4 #melanoma, a clinical trial helped Mary Elizabeth Williams defy the odds and survive cancer. She shares her inspiring story. #StandUpToCancer #MelanomaAwarenessMonth https://t.co/edeQjTUT0r

View on Twitter

Weather

Must Read

M	T	W	T	F	S	S
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30	31

Cancer Immunotherapy Drugs Driving End-of-Life Cost Increases

LEAVE A REPLY Cancel reply

Time Management Tips

Weather

Must Read

Awareness to Wellness: The Path to A World Without Cervical Cancer

NTRK gene fusions as novel targets of cancer therapy across multiple tumour types

A New Model for Oncology Second Opinion

High Discordance in Recs From Tumor Board and Sequencing Vendors

Chemo Is 'Invisible Threat' to Cancer Clinic Staff

POPULAR POSTS

Awareness to Wellness: The Path to A World Without Cervical Cancer

NTRK gene fusions as novel targets of cancer therapy across multiple...

A New Model for Oncology Second Opinion

POPULAR CATEGORY